Reduction of synaptojanin 1 improved amyloid-induced neuropathology and behavior deficits through accelerating Aβ clearance in one human Swedish APP and FAD (familial AD)-linked PS1 (presenilin-1) double mutant transgenic mouse (Zhu et al., 2013; Figure 1B). The gene discussed is PSEN1; the disease is amyloidosis.